{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:17Z","timestamp":1766040317546,"version":"3.48.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"DOI":"10.1007\/s11910-025-01473-z","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:40:45Z","timestamp":1766040045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Detection to Decision: Managing Device-Detected Atrial Fibrillation After Stroke"],"prefix":"10.1007","volume":"26","author":[{"given":"Nadja","family":"Korajkic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"1473_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jama.2024.22451","volume":"333","author":"D Ko","year":"2025","unstructured":"Ko D, Chung MK, Evans PT, Benjamin EJ, Helm RH. Atrial fibrillation: a review. JAMA. 2025;333:329\u201342. https:\/\/doi.org\/10.1001\/jama.2024.22451.","journal-title":"JAMA"},{"key":"1473_CR2","doi-asserted-by":"publisher","first-page":"e077209","DOI":"10.1136\/bmj-2023-077209","volume":"385","author":"N Vinter","year":"2024","unstructured":"Vinter N, Cordsen P, Johnsen SP, Staerk L, Benjamin EJ, Frost L, Trinquart L. Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study. BMJ. 2024;385:e077209. https:\/\/doi.org\/10.1136\/bmj-2023-077209.","journal-title":"BMJ"},{"key":"1473_CR3","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1161\/STROKEAHA.120.030812","volume":"52","author":"A Gabet","year":"2021","unstructured":"Gabet A, Guenancia C, Duloquin G, Oli\u00e9 V, B\u00e9jot Y. Ischemic stroke with atrial fibrillation: characteristics and time trends 2006 to 2017 in the Dijon stroke registry. Stroke. 2021;52:2077\u201385. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030812.","journal-title":"Stroke"},{"key":"1473_CR4","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478\u201386. https:\/\/doi.org\/10.1056\/NEJMoa1313600.","journal-title":"N Engl J Med"},{"key":"1473_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000533265","volume":"53","author":"ZY Wong","year":"2024","unstructured":"Wong ZY, Yuen LZH, Tan YK, Goh CXY, Teo YN, Ho JSY, et al. Detection of atrial fibrillation after ischemic stroke with an insertable cardiac monitor: a systematic review and individual patient data meta-analysis of randomized clinical trials. Cerebrovasc Dis. 2024;53:316\u201326. https:\/\/doi.org\/10.1159\/000533265.","journal-title":"Cerebrovasc Dis"},{"key":"1473_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jamacardio.2017.3180","volume":"2","author":"JA Reiffel","year":"2017","unstructured":"Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Pouliot E, Ziegler PD, Investigators ftRA. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a High-Risk population: the REVEAL AF study. JAMA Cardiol. 2017;2:1120\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2017.3180.","journal-title":"JAMA Cardiol"},{"key":"1473_CR7","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1161\/CIR.0000000000000740","volume":"140","author":"PA Noseworthy","year":"2019","unstructured":"Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA, et al. Subclinical and Device-Detected atrial fibrillation: pondering the knowledge gap: a scientific statement from the American heart association. Circulation. 2019;140:e944-63. https:\/\/doi.org\/10.1161\/CIR.0000000000000740.","journal-title":"Circulation"},{"key":"1473_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429\u201338. https:\/\/doi.org\/10.1016\/S1474-4422(13)70310-7.","journal-title":"Lancet Neurol"},{"key":"1473_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209949","volume":"103","author":"M Ghannam","year":"2024","unstructured":"Ghannam M, Al-Qudah AM, Alshaer QN, Kronmal R, Ntaios G, Childs CA, et al. Anticoagulation vs antiplatelets across subgroups of embolic stroke of undetermined source. Neurology. 2024;103:e209949. https:\/\/doi.org\/10.1212\/WNL.0000000000209949.","journal-title":"Neurology"},{"key":"1473_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(21)00067-3","volume":"20","author":"KG Haeusler","year":"2021","unstructured":"Haeusler KG, Kirchhof P, Kunze C, T\u00fct\u00fcnc\u00fc S, Fiessler C, Malsch C, et al. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. Lancet Neurol. 2021;20:426\u201336. https:\/\/doi.org\/10.1016\/S1474-4422(21)00067-3.","journal-title":"Lancet Neurol."},{"key":"1473_CR11","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2021.6128","volume":"325","author":"BH Buck","year":"2021","unstructured":"Buck BH, Hill MD, Quinn FR, Butcher KS, Menon BK, Gulamhusein S, Siddiqui M, Coutts SB, Jeerakathil T, Smith EE, et al. Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the PER DIEM randomized clinical trial. JAMA. 2021;325:2160\u20138. https:\/\/doi.org\/10.1001\/jama.2021.6128.","journal-title":"JAMA"},{"key":"1473_CR12","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/jama.2021.6470","volume":"325","author":"RA Bernstein","year":"2021","unstructured":"Bernstein RA, Kamel H, Granger CB, Piccini JP, Sethi PP, Katz JM, et al. Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: the STROKE-AF randomized clinical trial. JAMA. 2021;325:2169\u201377. https:\/\/doi.org\/10.1001\/jama.2021.6470.","journal-title":"JAMA"},{"key":"1473_CR13","doi-asserted-by":"publisher","first-page":"e1942","DOI":"10.1212\/WNL.0000000000200227","volume":"98","author":"G Tsivgoulis","year":"2022","unstructured":"Tsivgoulis G, Triantafyllou S, Palaiodimou L, Grory BM, Deftereos S, Kohrmann M, et al. Prolonged cardiac monitoring and stroke recurrence: a meta-analysis. Neurology. 2022;98:e1942\u201352. https:\/\/doi.org\/10.1212\/WNL.0000000000200227.","journal-title":"Neurology"},{"key":"1473_CR14","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1161\/STROKEAHA.122.037342","volume":"53","author":"AS Kim","year":"2022","unstructured":"Kim AS, Kamel H, Bernstein RA, Manchanda M, Caprio FZ. Controversies in stroke: should patients with embolic stroke of undetermined source undergo intensive heart rhythm monitoring with an implantable loop recorder? Stroke. 2022;53:3243\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.122.037342.","journal-title":"Stroke"},{"key":"1473_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-019-0207-9","volume":"3","author":"T Pereira","year":"2020","unstructured":"Pereira T, Tran N, Gadhoumi K, Pelter MM, Do DH, Lee RJ, et al. Photoplethysmography based atrial fibrillation detection: a review. NPJ Digit Med. 2020;3:3. https:\/\/doi.org\/10.1038\/s41746-019-0207-9.","journal-title":"NPJ Digit Med"},{"key":"1473_CR16","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45:3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"key":"1473_CR17","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","volume":"381","author":"MV Perez","year":"2019","unstructured":"Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381:1909\u201317.","journal-title":"N Engl J Med"},{"key":"1473_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.26599\/1671-5411.2024.03.005","volume":"21","author":"J Mathew","year":"2024","unstructured":"Mathew J, Mehawej J, Wang Z, Orwig T, Ding E, Filippaios A, et al. Health behavior outcomes in stroke survivors prescribed wearables for atrial fibrillation detection stratified by age. J Geriatr Cardiol. 2024;21:323\u201330. https:\/\/doi.org\/10.26599\/1671-5411.2024.03.005.","journal-title":"J Geriatr Cardiol"},{"key":"1473_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/europace\/euab036","volume":"23","author":"KT Koh","year":"2021","unstructured":"Koh KT, Law WC, Zaw WM, Foo DHP, Tan CT, Steven A, Samuel D, Fam TL, Chai CH, Wong ZS, et al. Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial. EP Europace. 2021;23:1016\u201323. https:\/\/doi.org\/10.1093\/europace\/euab036.","journal-title":"EP Europace"},{"key":"1473_CR20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","volume":"398","author":"JH Svendsen","year":"2021","unstructured":"Svendsen JH, Diederichsen SZ, Hojberg S, Krieger DW, Graff C, Kronborg C, Olesen MS, Nielsen JB, Holst AG, Brandes A, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet (London England). 2021;398:1507\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(21)01698-6.","journal-title":"Lancet (London England)"},{"key":"1473_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jamaneurol.2023.3931","volume":"80","author":"RA Bernstein","year":"2023","unstructured":"Bernstein RA, Kamel H, Granger CB, Piccini JP, Katz JM, Sethi PP, et al. Atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: 3-year results from the STROKE AF randomized clinical trial. JAMA Neurol. 2023;80:1277\u201383. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3931.","journal-title":"JAMA Neurol"},{"key":"1473_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ahj.2019.08.005","volume":"219","author":"R Passman","year":"2020","unstructured":"Passman R. Atrial fibrillation detection using implantable cardiac monitors: are we being too revealing? Am Heart J. 2020;219:137\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2019.08.005.","journal-title":"Am Heart J"},{"key":"1473_CR23","doi-asserted-by":"publisher","first-page":"i162","DOI":"10.1093\/eurheartjsupp\/suae088","volume":"27","author":"G Boriani","year":"2025","unstructured":"Boriani G, Tartaglia E, Trapanese P, Tritto F, Gerra L, Bonini N, Vitolo M, Imberti JF, Mei DA. Subclinical atrial fibrillation\/atrial high-rate episodes: what significance and decision-making? Eur Heart J Supplements: J Eur Soc Cardiol. 2025;27:i162\u20136. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suae088.","journal-title":"Eur Heart J Supplements: J Eur Soc Cardiol"},{"key":"1473_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/STROKEAHA.123.043665","volume":"55","author":"EE Smith","year":"2024","unstructured":"Smith EE, Yaghi S, Sposato LA, Fisher M. Atrial fibrillation detection and load: knowledge gaps related to stroke prevention. Stroke. 2024;55:205\u201313. https:\/\/doi.org\/10.1161\/STROKEAHA.123.043665.","journal-title":"Stroke"},{"key":"1473_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1177\/17474930241253482","volume":"19","author":"J D\u2019Lima","year":"2024","unstructured":"D\u2019Lima J, Thijs V, Lim HS, Rodrigues TS, Beaudoin AM. Temporal association between atrial fibrillation and ischemic stroke: systematic review and meta-analysis. Int J Stroke. 2024;19:1083\u201392. https:\/\/doi.org\/10.1177\/17474930241253482.","journal-title":"Int J Stroke"},{"issue":"10","key":"1473_CR26","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1161\/STROKEAHA.125.051749","volume":"56","author":"S Yaghi","year":"2025","unstructured":"Yaghi S, Sposato LA, Shu L, Garc\u00eda-Rodr\u00edguez D, Castro Urda V, Kreimer F, et al. Device-detected atrial fibrillation in patients with and without cryptogenic ischemia: the ANTARCTICA pooled analysis. Stroke. 2025:56(10):2895-2903 https:\/\/doi.org\/10.1161\/STROKEAHA.125.051749","journal-title":"Stroke"},{"key":"1473_CR27","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1016\/j.jacc.2019.09.050","volume":"74","author":"SZ Diederichsen","year":"2019","unstructured":"Diederichsen SZ, Haugan KJ, Brandes A, Lanng MB, Graff C, Krieger D, et al. Natural history of subclinical atrial fibrillation detected by implanted loop recorders. J Am Coll Cardiol. 2019;74:2771\u201381. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.050.","journal-title":"J Am Coll Cardiol"},{"key":"1473_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9583409","volume":"2020","author":"P Krisai","year":"2020","unstructured":"Krisai P, Aeschbacher S, Bossard M, Herber E, Blum S, Meyre P, et al. Change in atrial fibrillation burden over time in patients with nonpermanent atrial fibrillation. Cardiol Res Pract. 2020;2020:9583409. https:\/\/doi.org\/10.1155\/2020\/9583409.","journal-title":"Cardiol Res Pract"},{"key":"1473_CR29","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/pace.15072","volume":"47","author":"W Mekary","year":"2024","unstructured":"Mekary W, Campbell M, Bhatia NK, Westerman S, Shah A, Leal M, et al. Spontaneous fluctuation in atrial fibrillation burden and duration in patients with implantable loop monitors. Pacing Clin Electrophysiol. 2024;47:1454\u201363. https:\/\/doi.org\/10.1111\/pace.15072.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1473_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1161\/STROKEAHA.120.031822","volume":"52","author":"YJ Park","year":"2021","unstructured":"Park YJ, Kim JS, Park K-M, On YK, Park S-J. Subclinical atrial fibrillation burden and adverse clinical outcomes in patients with permanent pacemakers. Stroke. 2021;52:1299\u2013308. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031822.","journal-title":"Stroke"},{"key":"1473_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(23)00326-5","volume":"23","author":"LA Sposato","year":"2024","unstructured":"Sposato LA, Field TS, Schnabel RB, Wachter R, Andrade JG, Hill MD. Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurol. 2024;23:110\u201322.","journal-title":"Lancet Neurol"},{"key":"1473_CR32","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","volume":"45","author":"N Becher","year":"2024","unstructured":"Becher N, Metzner A, Toennis T, Kirchhof P, Schnabel RB. Atrial fibrillation burden: a new outcome predictor and therapeutic target. Eur Heart J. 2024;45:2824\u201338. https:\/\/doi.org\/10.1093\/eurheartj\/ehae373.","journal-title":"Eur Heart J"},{"key":"1473_CR33","doi-asserted-by":"publisher","first-page":"e010304","DOI":"10.1161\/CIRCEP.121.010304","volume":"15","author":"DS Chew","year":"2022","unstructured":"Chew DS, Li Z, Steinberg BA, O\u2019Brien EC, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, et al. Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices. Circulation Arrhythmia Electrophysiol. 2022;15:e010304. https:\/\/doi.org\/10.1161\/CIRCEP.121.010304.","journal-title":"Circulation Arrhythmia Electrophysiol"},{"key":"1473_CR34","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.jacep.2024.06.020","volume":"10","author":"G Peigh","year":"2024","unstructured":"Peigh G, Koehler J, Majumder S, Cho Y, Landman SR, Sarkar S, et al. Associations between changes in maximum daily atrial fibrillation duration, ischemic stroke, and mortality. JACC Clin Electrophysiol. 2024;10:2394\u2013406. https:\/\/doi.org\/10.1016\/j.jacep.2024.06.020.","journal-title":"JACC Clin Electrophysiol"},{"key":"1473_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeae061","volume":"4","author":"PA Chousou","year":"2024","unstructured":"Chousou PA, Chattopadhyay RK, Matthews G, Clark A, Vassiliou VS, Pugh PJ. The incidence of atrial fibrillation detected by implantable loop recorders: a comparison between patients with and without embolic stroke of undetermined source. Eur Heart J Open. 2024;4:oeae061. https:\/\/doi.org\/10.1093\/ehjopen\/oeae061.","journal-title":"Eur Heart J Open"},{"key":"1473_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.123.012394","volume":"17","author":"JP Piccini","year":"2024","unstructured":"Piccini JP, Stanelle EJ, Johnson CC, Hylek EM, Kanwar R, Lakkireddy DR, et al. Performance of atrial fibrillation burden trends for stroke risk stratification. Circ Arrhythm Electrophysiol. 2024;17:e012394. https:\/\/doi.org\/10.1161\/CIRCEP.123.012394.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1473_CR37","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/jce.15866","volume":"34","author":"G Peigh","year":"2023","unstructured":"Peigh G, Passman RS. Pill-in-pocket\" anticoagulation for stroke prevention in atrial fibrillation. J Cardiovasc Electrophysiol. 2023;34:2152\u20137. https:\/\/doi.org\/10.1111\/jce.15866.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1473_CR38","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jamaneurol.2022.3031","volume":"79","author":"SZ Diederichsen","year":"2022","unstructured":"Diederichsen SZ, Frederiksen KS, Xing LY, Haugan KJ, H\u00f8jberg S, Brandes A, Graff C, Olesen MS, Krieger D, K\u00f8ber L. Severity and etiology of incident stroke in patients screened for atrial fibrillation vs usual care and the impact of prior stroke: a post hoc analysis of the LOOP randomized clinical trial. JAMA Neurol. 2022;79:997\u20131004.","journal-title":"JAMA Neurol"},{"key":"1473_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, et al. Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med. 2024;390:107\u201317. https:\/\/doi.org\/10.1056\/NEJMoa2310234.","journal-title":"N Engl J Med"},{"key":"1473_CR40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","volume":"389","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, et al. Anticoagulation with edoxaban in patients with atrial high-rate episodes. N Engl J Med. 2023;389:1167\u201379.","journal-title":"N Engl J Med"},{"key":"1473_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","volume":"149","author":"WF McIntyre","year":"2024","unstructured":"McIntyre WF, Benz AP, Becher N, Healey JS, Granger CB, Rivard L, et al. Direct oral anticoagulants for stroke prevention in patients with Device-Detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and artesia trials. Circulation. 2024;149:981\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067512.","journal-title":"Circulation"},{"key":"1473_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2024.01.002","volume":"123","author":"G Boriani","year":"2024","unstructured":"Boriani G, Gerra L, Mei DA, Bonini N, Vitolo M, Proietti M, Imberti JF. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: what decision making on anticoagulation after the NOAH and artesia trials? Eur J Intern Med. 2024;123:37\u201341. https:\/\/doi.org\/10.1016\/j.ejim.2024.01.002.","journal-title":"Eur J Intern Med"},{"key":"1473_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamaneurol.2024.0673","volume":"81","author":"JE Siegler","year":"2024","unstructured":"Siegler JE, Sposato LA, Yaghi S. Toward more personalized management of device-detected atrial fibrillation. JAMA Neurol. 2024;81:573\u20134. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0673.","journal-title":"JAMA Neurol"},{"key":"1473_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(24)00475-7","volume":"24","author":"A Shoamanesh","year":"2025","unstructured":"Shoamanesh A, Field TS, Coutts SB, Sharma M, Gladstone D, Hart RG, et al. Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial. Lancet Neurol. 2025;24:140\u201351. https:\/\/doi.org\/10.1016\/S1474-4422(24)00475-7.","journal-title":"Lancet Neurol"},{"key":"1473_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036429","volume":"13","author":"HC Diener","year":"2024","unstructured":"Diener HC, Becher N, Sehner S, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al. Anticoagulation in patients with device-detected atrial fibrillation with and without a prior stroke or transient ischemic attack: the NOAH-AFNET 6 trial. J Am Heart Assoc. 2024;13:e036429. https:\/\/doi.org\/10.1161\/JAHA.124.036429.","journal-title":"J Am Heart Assoc"},{"key":"1473_CR46","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1093\/eurheartj\/ehae596","volume":"45","author":"RB Schnabel","year":"2024","unstructured":"Schnabel RB, Benezet-Mazuecos J, Becher N, McIntyre WF, Fierenz A, Lee SF, Goette A, Atar D, Bertaglia E, Benz AP. Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and artesia trials. Eur Heart J. 2024;45:4902\u201316.","journal-title":"Eur Heart J"},{"issue":"9","key":"1473_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/17474930251341101","volume":"20","author":"F Mele","year":"2025","unstructured":"Mele F, Scopelliti G, La Volpe L, Ferrari Aggradi C, Molitierno N, Cova I, et al. Prediction scores of subclinical atrial fibrillation in patients with cryptogenic stroke and transient ischemic attack. Int J Stroke. 2025;17474930251341101. https:\/\/doi.org\/10.1177\/17474930251341101.","journal-title":"Int J Stroke"},{"key":"1473_CR48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/STROKEAHA.123.044813","volume":"55","author":"Y Shimada","year":"2024","unstructured":"Shimada Y, Todo K, Doijiri R, Yamazaki H, Sonoda K, Koge J, Iwata T, Ueno Y, Yamagami H, Kimura N, et al. Higher frequency of premature atrial contractions correlates with atrial fibrillation detection after cryptogenic stroke. Stroke. 2024;55:946\u201353. https:\/\/doi.org\/10.1161\/STROKEAHA.123.044813.","journal-title":"Stroke"},{"key":"1473_CR49","doi-asserted-by":"publisher","first-page":"e1775","DOI":"10.1212\/WNL.0000000000012769","volume":"97","author":"A Cameron","year":"2021","unstructured":"Cameron A, Cheng HK, Lee R-P, Doherty D, Hall M, Khashayar P, et al. Biomarkers for atrial fibrillation detection after stroke: systematic review and meta-analysis. Neurology. 2021;97:e1775-89. https:\/\/doi.org\/10.1212\/WNL.0000000000012769.","journal-title":"Neurology"},{"key":"1473_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.034512","volume":"14","author":"KG Haeusler","year":"2025","unstructured":"Haeusler KG, Tutuncu S, Fiessler C, Jawad-Ul-Qamar M, Kunze C, Schurig J, et al. Excessive supraventricular ectopic activity in patients with acute ischemic stroke is associated with atrial fibrillation detection within 24 months after stroke: a predefined analysis of the MonDAFIS study. J Am Heart Assoc. 2025;14:e034512. https:\/\/doi.org\/10.1161\/JAHA.123.034512.","journal-title":"J Am Heart Assoc"},{"key":"1473_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/23969873231211166","volume":"9","author":"H Stengl","year":"2024","unstructured":"Stengl H, Ganeshan R, von Rennenberg R, Hellwig S, Herm J, Krause T, et al. Heart rate turbulence in acute ischemic stroke. Eur Stroke J. 2024;9:226\u201334. https:\/\/doi.org\/10.1177\/23969873231211166.","journal-title":"Eur Stroke J"},{"key":"1473_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead039","volume":"3","author":"J Saberniak","year":"2023","unstructured":"Saberniak J, Skrebelyte-Strom L, Orstad EB, Hilde JM, Solberg MG, Ronning OM, et al. Left atrial appendage strain predicts subclinical atrial fibrillation in embolic strokes of undetermined source. Eur Heart J Open. 2023;3:oead039. https:\/\/doi.org\/10.1093\/ehjopen\/oead039.","journal-title":"Eur Heart J Open"},{"key":"1473_CR53","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1007\/s00415-023-11942-5","volume":"270","author":"Y Ueno","year":"2023","unstructured":"Ueno Y, Miyamoto N, Hira K, Doijiri R, Yamazaki H, Sonoda K, Koge J, Iwata T, Todo K, Yamagami H, et al. Left atrial appendage flow velocity predicts occult atrial fibrillation in cryptogenic stroke: a CRYPTON-ICM registry. J Neurol. 2023;270:5878\u201388. https:\/\/doi.org\/10.1007\/s00415-023-11942-5.","journal-title":"J Neurol"},{"key":"1473_CR54","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209625","volume":"103","author":"AC Cameron","year":"2024","unstructured":"Cameron AC, Arnold M, Katsas G, Yang J, Quinn TJ, Abdul-Rahim AH, et al. Natriuretic peptides to classify risk of atrial fibrillation detection after stroke. Neurology. 2024;103:e209625. https:\/\/doi.org\/10.1212\/WNL.0000000000209625.","journal-title":"Neurology"},{"key":"1473_CR55","doi-asserted-by":"publisher","unstructured":"D\u2019Anna L, Prandin G, Valente M, Zhang L, Malhotra P, Sacco S, Foschi M, Ornello R, Levee V, Chulack K, et al. C-reactive protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis. Int J Stroke: Official J Int Stroke Soc. 2025;17474930251332489. https:\/\/doi.org\/10.1177\/17474930251332489.","DOI":"10.1177\/17474930251332489"},{"key":"1473_CR56","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034994","volume":"13","author":"J Hannemann","year":"2024","unstructured":"Hannemann J, Wasser K, Mileva Y, Kleinsang F, Schubert M, Schwedhelm E, et al. Symmetric dimethylarginine predicts previously undetected atrial fibrillation in patients with ischemic stroke. J Am Heart Assoc. 2024;13:e034994. https:\/\/doi.org\/10.1161\/JAHA.124.034994.","journal-title":"J Am Heart Assoc"},{"key":"1473_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2025.101611","volume":"56","author":"K Yoshikawa","year":"2025","unstructured":"Yoshikawa K, Asano T, Onishi Y, Takai Y, Sugiyama H, Arai S, et al. Combining D-dimer and LDL\/HDL ratio to predict the absence of atrial fibrillation in patients with an implantable loop recorder for embolic stroke of undetermined source. IJC Heart & Vasculature. 2025;56:101611. https:\/\/doi.org\/10.1016\/j.ijcha.2025.101611.","journal-title":"IJC Heart & Vasculature"},{"key":"1473_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/ehjdh\/ztaf102","author":"G Boriani","year":"2025","unstructured":"Boriani G, Brachmann J, Lewalter T, Wright DJ, Badertscher P, Gale CP, Merino JL, P\u00fcrerfellner H, Lip GYH. Access and reimbursement of ambulatory cardiac monitoring across Europe. Eur Heart J - Digit Health. 2025. https:\/\/doi.org\/10.1093\/ehjdh\/ztaf102.","journal-title":"Eur Heart J - Digit Health"},{"key":"1473_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amjcard.2023.06.040","volume":"202","author":"SJ Apple","year":"2023","unstructured":"Apple SJ, Flomenbaum D, Parker M, Chhikara S, Stolarov A, Moser J, et al. Low utility of short-term rhythm assessment before long-term rhythm monitoring in patients with cryptogenic stroke. Am J Cardiol. 2023;202:151\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.040.","journal-title":"Am J Cardiol"},{"key":"1473_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/cer-2020-0224","volume":"10","author":"LM Sawyer","year":"2021","unstructured":"Sawyer LM, Witte KK, Reynolds MR, Mittal S, Grimsey Jones FW, Rosemas SC, Ziegler PD, Kaplon RE, Yaghi S. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. J Comp Eff Res. 2021;10:127\u201341. https:\/\/doi.org\/10.2217\/cer-2020-0224.","journal-title":"J Comp Eff Res"},{"key":"1473_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24050","volume":"24","author":"SJ Edwards","year":"2020","unstructured":"Edwards SJ, Wakefield V, Jhita T, Kew K, Cain P, Marceniuk G. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation. Health Technol Assess (Winchester Eng). 2020;24:1\u2013184. https:\/\/doi.org\/10.3310\/hta24050.","journal-title":"Health Technol Assess (Winchester Eng)"},{"key":"1473_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12872-023-03073-6","volume":"23","author":"MSV Elkind","year":"2023","unstructured":"Elkind MSV, Witte KK, Kasner SE, Sawyer LM, Grimsey Jones FW, Rinciog C, Tsintzos S, Rosemas SC, Lanctin D, Ziegler PD, et al. Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US. BMC Cardiovasc Disord. 2023;23:45. https:\/\/doi.org\/10.1186\/s12872-023-03073-6.","journal-title":"BMC Cardiovasc Disord"},{"key":"1473_CR63","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/joa3.12586","volume":"37","author":"V Thijs","year":"2021","unstructured":"Thijs V, Witte KK, Guarnieri C, Makino K, Tilden D, Gillespie J, et al. Cost-effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia. J Arrhythm. 2021;37:1077\u201385. https:\/\/doi.org\/10.1002\/joa3.12586.","journal-title":"J Arrhythm"},{"key":"1473_CR64","doi-asserted-by":"publisher","first-page":"CVII","DOI":"10.1177\/23969873221099478","volume":"7","author":"M Rubiera","year":"2022","unstructured":"Rubiera M, Aires A, Antonenko K, L\u00e9meret S, Nolte CH, Putaala J, et al. European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin. Eur Stroke J. 2022;7:CVII\u2013CXXXIX. https:\/\/doi.org\/10.1177\/23969873221099478.","journal-title":"Eur Stroke J"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01473-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01473-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01473-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:40:49Z","timestamp":1766040049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01473-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01473-z","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Disclosure statement: NK has no relevant interests to disclose. VT reports speaker fees for Boehringer Ingelheim and Astra Zeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1"}}